Serina Therapeutics Inc (SER)

Serina Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.76	7.62	0.53	0.63	0.53	2.35
Cash & Cash Equivalents	8.76	7.62	0.53	0.63	0.53	2.35
Cash Growth	2553.33%	1331.53%	-16.05%	20.30%	-77.59%	-64.93%
Receivables	0.07	0	0	0.03	0.33	0.36
Other Current Assets	0.12	0	0.02	1.58	1.43	1.34
Total Current Assets	8.94	7.62	0.55	2.23	2.28	4.05
Property, Plant & Equipment	1.3	1.35	0.31	0	0	1.13
Goodwill and Intangibles	0.57	0	0	0.87	1.59	2.15
Other Long-Term Assets	0.05	0	0	0.05	0.05	0.11
Total Long-Term Assets	1.92	1.35	0.31	0.92	1.64	3.39
Total Assets	10.86	8.97	0.86	3.15	3.93	7.44
Accounts Payable	4.08	1.16	0.14	0.84	1.73	1.65
Deferred Revenue	0	0	0.15	0	0.34	0.28
Current Debt	9.98	0.25	0.13	7.14	2.4	0.43
Other Current Liabilities	0	0	0.01	0.99	0.9	0.94
Total Current Liabilities	14.06	1.41	0.44	8.97	5.36	3.3
Long-Term Debt	1.11	3.45	1.68	6.06	3.9	1.53
Other Long-Term Liabilities	0	0	1.08	0	0.06	0
Total Long-Term Liabilities	1.11	3.45	2.76	6.06	3.96	1.53
Total Liabilities	15.17	4.86	3.19	15.03	9.32	4.83
Total Debt	11.08	3.7	1.81	13.2	6.3	1.96
Debt Growth	-63.12%	103.67%	-86.26%	109.69%	221.88%	-
Retained Earnings	-5.44	-33.18	-38.45	-105.75	-97.07	-86.21
Comprehensive Income	0	0	0	0	0.14	0.07
Shareholders' Equity	-4.31	-32.29	-37.78	-11.83	-5.12	2.22
Net Cash / Debt	-2.33	3.92	-1.28	-12.57	-5.77	0.4
Net Cash / Debt Growth	-	-	-	-	-	-94.10%
Net Cash Per Share	-0.83	0.98	-0.60	-11.67	-5.39	0.37
Working Capital	-5.12	6.21	0.11	-6.73	-3.07	0.76
Book Value Per Share	-1.54	-14.11	-17.61	-10.98	-4.78	2.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).